NasdaqCM - Delayed Quote USD

Avid Bioservices, Inc. (CDMO)

7.35 +0.03 (+0.41%)
At close: April 26 at 4:00 PM EDT
7.35 0.00 (0.00%)
After hours: April 26 at 6:31 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Total Revenue
136,735.00
149,266.00
119,597.00
95,868.00
59,702.00
Cost of Revenue
126,526.00
117,786.00
82,949.00
66,561.00
55,770.00
Gross Profit
10,209.00
31,480.00
36,648.00
29,307.00
3,932.00
Operating Expense
26,761.00
27,879.00
21,226.00
17,064.00
14,517.00
Operating Income
-16,552.00
3,601.00
15,422.00
12,243.00
-10,585.00
Net Non Operating Interest Income Expense
-2,773.00
-2,600.00
-2,680.00
-1,164.00
-8.00
Other Income Expense
-1,411.00
1,002.00
-81.00
133.00
127.00
Pretax Income
-20,736.00
2,003.00
12,661.00
11,212.00
-10,466.00
Tax Provision
-3,053.00
1,443.00
-115,011.00
--
--
Net Income Common Stockholders
-17,683.00
560.00
127,672.00
3,318.00
-15,152.00
Average Dilution Earnings
--
--
1,954.00
--
--
Diluted NI Available to Com Stockholders
-17,683.00
560.00
129,626.00
3,318.00
-15,152.00
Basic EPS
-0.28
0.01
2.08
0.06
-0.27
Diluted EPS
-0.28
0.01
1.84
0.06
-0.27
Basic Average Shares
62,970.75
62,268.00
61,484.00
58,222.00
56,326.00
Diluted Average Shares
63,383.75
63,782.00
70,474.00
59,426.00
56,326.00
Total Operating Income as Reported
-16,552.00
3,601.00
15,422.00
12,243.00
-10,940.00
Total Expenses
153,287.00
145,665.00
104,175.00
83,625.00
70,287.00
Net Income from Continuing & Discontinued Operation
-17,683.00
560.00
127,672.00
11,212.00
-10,466.00
Normalized Income
-17,683.00
560.00
127,672.00
11,212.00
-10,111.00
Interest Income
--
--
--
133.00
474.00
Interest Expense
2,773.00
2,600.00
2,680.00
1,164.00
8.00
Net Interest Income
-2,773.00
-2,600.00
-2,680.00
-1,164.00
-8.00
EBIT
-17,963.00
4,603.00
15,341.00
12,376.00
-10,458.00
EBITDA
-7,829.00
11,813.00
19,821.00
15,829.00
-7,367.00
Reconciled Cost of Revenue
126,526.00
117,786.00
82,949.00
66,561.00
55,770.00
Reconciled Depreciation
10,134.00
7,210.00
4,480.00
3,453.00
3,091.00
Net Income from Continuing Operation Net Minority Interest
-17,683.00
560.00
127,672.00
11,212.00
-10,466.00
Total Unusual Items Excluding Goodwill
--
--
--
--
-355.00
Total Unusual Items
--
--
--
--
-355.00
Normalized EBITDA
-7,829.00
11,813.00
19,821.00
15,829.00
-7,012.00
Tax Rate for Calcs
0.00
0.00
0.00
--
--
4/30/2020 - 4/4/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
 
GLTO Galecto, Inc.
0.7048
+5.62%
 
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
 
IMNN Imunon, Inc.
1.4400
0.00%
 
RNA Avidity Biosciences, Inc.
24.36
+2.22%
 
TRDA Entrada Therapeutics, Inc.
12.45
+0.73%
 
ABIO ARCA biopharma, Inc.
3.5800
+2.87%
 
RANI Rani Therapeutics Holdings, Inc.
6.68
+1.83%
 
COGT Cogent Biosciences, Inc.
6.02
+0.17%
 
SILO Silo Pharma, Inc.
1.8500
-2.63%